Free Neuropathology (Mar 2024)

Blocking TGF-β- and Epithelial-to-Mesenchymal Transition (EMT)-mediated activation of brain pericytes in glioblastoma impacts tumor angiogenesis

  • Luisa Merk,
  • Katja Regel,
  • Hermann Eckhardt,
  • Marietheres Evers,
  • Ali El-Ayoubi,
  • Michel Mittelbronn,
  • Marcel Krüger,
  • Jean-Jacques Gérardy,
  • Andreas F. Mack,
  • Ulrike Naumann

DOI
https://doi.org/10.17879/freeneuropathology-2024-5188
Journal volume & issue
Vol. 5

Abstract

Read online

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. GBM displays excessive and unfunctional vascularization which may, among others, be a reason for its devastating prognosis. Pericytes have been identified as the major component of the irregular vessel structure in GBM. In vitro data suggest an epithelial-to-mesenchymal transition (EMT)-like activation of glioma-associated pericytes (GA-Peris), stimulated by GBM-secreted TGF-β, to be involved in the formation of a chaotic and dysfunctional tumor vasculature. This study investigated whether TGF-β impacts pericyte functions in vivo via the induction of the EMT transcription factor SLUG and whether this is associated with the development of GBM-associated vascular abnormalities. Upon prohibiting the TGF-β-/SLUG-mediated EMT induction in GA-Peris, the number of PDGFRβ and αSMA positive pericytes was significantly reduced, regardless of whether TGF-β secretion by GBM cells was blocked or whether SLUG was specifically knocked out in GA-Peris. The reduced amount of PDGFRβ+ or αSMA+ pericytes observed under those conditions correlated with a lower vessel density and fewer vascular abnormalities. Our data provide evidence that the SLUG-mediated modulation of pericyte activity is induced by GBM-secreted TGF-β­ and that activated pericytes are key contributors in neo-angiogenic processes. We suggest that a pathologically altered activation of GA-Peris in the tumor microenvironment is responsible for the unstructured tumor vasculature. There is emerging evidence that vessel normalization alleviates tumor hypoxia, reduces tumor-associated edema and improves drug delivery. Therefore, avoiding the generation of an unstructured and non-functional tumor vasculature during tumor recurrence might be a promising treatment approach for GBM and identifies pericytes as a potential novel therapeutic target.

Keywords